Antipsychotic Drugs Associated with Abnormal Muscle Movements
The FDA acted today on reports that researchers linked several popular antipsychotic drugs with abnormal muscle movements and withdrawal symptoms in newborns. The FDA mandated new drug labels. They will contain additional and consistent information about the potential risk for abnormal muscle movements. These movements are extrapyramidal signs or EPS. Plus, the label will include
Read More